Grown Rogue International (GRUSF) Operating Expenses (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Operating Expenses of $3.9 million for Q1 2026, down 5.28% year-over-year from $4.1 million in Q1 2025, and up 100.0% quarter-over-quarter from -$9576.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Operating Expenses (2009 - 2026) Analysis & Trends
Grown Rogue International's Operating Expenses history runs 18 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 5.28% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at -$6359.3 billion (down 315.77% YoY), while the FY2025 annual figure was $14.7 million, up 11.81% from the prior year.
- Operating Expenses for Q1 2026 stood at $3.9 million, up from -$9576.3 billion in the prior quarter.
- The five-year high for Operating Expenses was $3217.0 billion in Q3 2025, with the low at -$9576.3 billion in Q4 2025.
- The 5-year median for Operating Expenses is $2.8 million (2025), against an average of -$243.7 billion.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses jumped 74.77% in 2025, then fell 5.28% in 2026.
- Grown Rogue International's Operating Expenses stood at $1.8 million in 2022, then climbed by 6.49% to $1.9 million in 2023, then surged by 151557942.19% to $2947.2 billion in 2024, then slumped by 424.93% to -$9576.3 billion in 2025, then soared by 100.0% to $3.9 million in 2026.
- Business Quant data shows GRUSF's Operating Expenses at $3.9 million in Q1 2026, -$9576.3 billion in Q4 2025, and $3217.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.53 Mn |
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | -9,576.29 Bn |
| Sep 30, 2025 | 3,217.04 Bn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Sep 30, 2024 | 2,947.23 Bn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Oct 31, 2023 | 5.68 Mn |
| Jul 31, 2023 | 3.51 Mn |
| Apr 30, 2023 | 1.77 Mn |
| Jan 31, 2023 | 1.87 Mn |
| Jan 31, 2022 | 1.83 Mn |
| Jul 31, 2021 | 1.53 Mn |
| Apr 30, 2021 | 1.23 Mn |
| Jan 31, 2021 | 1.27 Mn |
| Oct 31, 2020 | 629,483.00 |
| Jul 31, 2020 | 1.27 Mn |